<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Slotman, Ben</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Prophylactic Cranial Irradiation in Extensive Disease Small Cell Lung Cancer</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">13-14</style></pages><abstract><style  face="normal" font="default" size="100%">Percutaneous cranial irradiation (PCI) has had benefit for patients with limited disease small cell lung cancer (SCLC). The findings of a study now indicate that PCI also has benefit in the setting of extensive disease-SCLC, where the risk of brain metastases is high. This article discusses the findings of a study in which PCI led to a significant reduction in the risk of symptomatic brain metastases and a significant prolongation of survival.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>